Pharvaris NV (PHVS)

NASDAQ · Pharmaceuticals

35.97
+0.65 (+1.83%)
Updated Aug 18, 2:31 PM ET
AI Rating
Buy
Overall Score
66
Trend
72
Momentum
76
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Pharvaris NV is trading at $35.97, up 1.83% on the session. The 50 day average sits at $33.64 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 54.3, which reads as neutral, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $33.01 with resistance near $35.54, so that band frames the current range. Average daily movement is roughly $1.90, or about 5.3% of the share price, which is what any stop placement has to allow for. The overall health score of 66 out of 100 combines a trend score of 72, momentum of 76 and a risk score of 44.

Technical indicators

RSI (14)
54.3
neutral
MACD
0.379
bullish crossover
SMA 20
34.02
SMA 50
33.64
SMA 200
--
unknown
ATR (14)
1.90
avg daily range
Support
33.01
Resistance
35.54
Volume vs 20d
1.89x
volume spike
Volatility
52.9%
annualised
1 month
+4.40%
3 months
+14.46%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.